NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
|A drug used with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (IL-2), and 13-cis-retinoic acid to treat high-risk neuroblastoma. It is used in children whose disease has improved with other anticancer treatment. MOAB Ch14.18 binds to a substance called GD2, which is found on some types of cancer cells. MOAB Ch14.18 may block GD2 and help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called Ch14.18, dinutuximab, monoclonal antibody Ch14.18, and Unituxin.|